Nicholas J Geraghty (N J Geraghty)

Scopus Author ID Loop profile UOW Scholars ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

Cells

Purinergic signalling

International journal of molecular sciences

Science advances

University of Wollongong

University of Wollongong (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Wollongong

Australia

Post-Doctoral Fellow :: School of Chemistry and Molecular Bioscience

University of Wollongong

Australia

PhD Candidate

Education History

University of Wollongong

Australia

PHD :: School of Biological Sciences

University of Wollongong

Australia

BSC :: School of Biological Sciences

Publications

Ross J Turner, Thomas V Guy, Nicholas J Geraghty, Ashleigh Splitt, Debbie Watson, Daniel Brungs, Martin G Carolan, Andrew A Miller, Jeremiah F de Leon, Morteza Aghmesheh, Ronald Sluyter
Low Pretreatment CD4 + :CD8 + T Cell Ratios and CD39 + CD73 + CD19 + B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (16) (2023)
Nicholas J Geraghty, Sandeep Satapathy, Mark R Wilson
The Emerging Roles of Extracellular Chaperones in Complement Regulation. Cells 11 (23) (2022)
Nicholas J Geraghty, Sandeep Satapathy, Mark R Wilson
The Emerging Roles of Extracellular Chaperones in Complement Regulation. Cells 11 (23) (2022)
Nicholas J Geraghty, Sandeep Satapathy, Mark R Wilson
The Emerging Roles of Extracellular Chaperones in Complement Regulation. Cells 11 (23) (2022)
Nicholas J Geraghty, Sandeep Satapathy, Mark R Wilson
The Emerging Roles of Extracellular Chaperones in Complement Regulation. Cells 11 (23) (2022)
Debbie Watson, Sam R Adhikary, Peter Cuthbertson, Nicholas J Geraghty, Katrina M Bird, Amal Elhage, Chloe Sligar, Ronald Sluyter
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease. Methods in molecular biology (Clifton, N.J.) 2510 (2022)
Jennifer West, Sandeep Satapathy, Carolyn M Sue, Megan A Kelly, Nicholas J Geraghty, Emma-Jayne Proctor, Pietro Sormanni, Christopher M Dobson, Joel N Buxbaum, Marie Ranson, Mark R Wilson
Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation. Science advances 7 (50) (2021)
Peter Cuthbertson, Nicholas J Geraghty, Sam R Adhikary, Katrina M Bird, Stephen J Fuller, Debbie Watson, Ronald Sluyter
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease. International journal of molecular sciences 22 (15) (2021)
Ross J Turner, Nicholas J Geraghty, Jonathan G Williams, Diane Ly, Daniel Brungs, Martin G Carolan, Thomas V Guy, Debbie Watson, Jeremiah F de Leon, Ronald Sluyter
Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73. Purinergic signalling 16 (3) (2020)
Diane Ly, Anjila Dongol, Peter Cuthbertson, Thomas V Guy, Nicholas J Geraghty, Reece Andrew Sophocleous, Lucia Sin, Bradley J Turner, Debbie Watson, Justin J Yerbury, Ronald Sluyter
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic signalling 16 (1) (2020)
Nicholas J Geraghty, Debbie Watson, Ronald Sluyter
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Immunology and cell biology 97 (6) (2019)
Nicholas J Geraghty, L Belfiore, D Ly, S R Adhikary, S J Fuller, W Varikatt, M L Sanderson-Smith, V Sluyter, S I Alexander, R Sluyter, D Watson
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease. Clinical and experimental immunology 190 (1) (2017)

Nicholas J Geraghty.css-eqlu8i{font-size:small;padding-left:4px;} (N J Geraghty)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas J Geraghty (N J Geraghty)